key: cord-0951874-ox2sw33g
authors: Eigenmann, Philippe
title: Comments on metabolomics in asthma and atopic dermatitis, and patient care during the COVID‐19 pandemic
date: 2021-10-31
journal: Pediatr Allergy Immunol
DOI: 10.1111/pai.13664
sha: b3ae21d071fa88cc6599314b614e46d9ef4d3f5e
doc_id: 951874
cord_uid: ox2sw33g

nan

The second editor's choice of this issue addresses the influence of microorganism-derived metabolites on allergy and more specifically on the various phenotypes of atopic dermatitis. Chiu Chih-Yung et al. 10 recruited children and adolescents with atopic dermatitis as well as healthy controls with the aim to investigate the metabolic impact on filaggrin mutations and IgE responses in atopic dermatitis. They sequenced the filaggrin gene and measured plasma metabolites by magnetic resonance spectroscopy, and found that nitrogen and amino acid metabolism for energy production were associated with atopic dermatitis, as well as with microbe-related methane and propranoate metabolism. Further, they found an association of various metabolites with specific filaggrin mutations, also positively correlating with total IgE serum levels. They conclude by suggesting that a diverse microbial community structure related to hosting genetics is contributing to environmental allergic responses in the pathogenesis of atopic dermatitis.

The third editor's choice article is directly related to patient care during the COVID-19 pandemic. The pandemic definitely has severely changed the care of our allergy patients. First, we had to determine whether allergy treatments were not augmenting the risk of getting infected or of having a more severe case of COVID-19. Patients and the medical community could then be reassured that allergy medications could be prescribed and used without harm. 11 Furthermore, lockdowns in many countries prevented allergy patients getting regular care at medical offices or in clinics, making common the use of alternative methods such as telemedicine. 12, 13 In this regard, assuring continuous availability of food challenges represented a major challenge as the waiting list is already long in many clinical settings. To overcome this problem during the pandemic, Byrne and colleagues used a COVID-19 medical facility equipped with hospital beds and monitors. 14 They brought onsite allergy consultants and anesthetic cover and did set up operational facilities with the capacity of 27 oral food challenge per day. In this facility, almost 500 food challenges were completed with approximately one-third positive food challenge, with 1 out of 20 causing anaphylaxis. Thanks to this setting, they could reduce the waiting list by two-thirds in only 3 weeks of time. The authors concluded that the unusual situation provoked by the pandemic allowed the development of new procedures to reduce the waiting list of food challenges, showing that a flexible model of service delivery may also help to solve practical scheduling problems outside of the pandemic setting. State-of-the-art clinical care for food challenges according to current standards was provided throughout the service. [15] [16] [17] Chiu Chih-Yung Aideen Byrne

Known and potential molecules associated with altered B cell development leading to predominantly antibody deficiencies

A role for metabolism in determining neonatal immune function

Metabolomic differences of exhaled breath condensate among children with and without asthma

Metabolomics reveals a correlation between hydroxyeicosatetraenoic acids and allergic asthma: evidence from three years' immunotherapy

Association of respiratory viruses with serum metabolome in infants with severe bronchiolitis

Respiratory viruses are associated with serum metabolome among infants hospitalized for bronchiolitis: a multicenter study

Gut microbial-derived butyrate is inversely associated with IgE responses to allergens in childhood asthma

Prenatal high molecular weight phthalates and bisphenol A, and childhood respiratory and allergic outcomes

Serum chitinase-like protein YKL-40 is linked to small airway function in children with asthmatic symptoms

Metabolomics reveals microbial-derived metabolites associated with immunoglobulin E responses in filaggrinrelated atopic dermatitis

Managing childhood allergies and immunodeficiencies during respiratory virus epidemics -The 2020 COVID-19 pandemic: a statement from the EAACI-section on pediatrics

COVID-19 and allergy: how to take care of allergic patients during a pandemic?

Telemedicine for allergic patients during COVID-19

Mass food challenges in a vacant COVID-19 stepdown facility: exceptional opportunity provides a model for the future

Regional centres conduct food challenges with outcomes equivalent to a tertiary pediatric hospital

Are oral food challenges for introduction of high-risk foods in children with food protein-induced enterocolitis syndrome needed?

The severity of reaction after food challenges depends on the indication: a prospective multicenter study